On the basis of the record ^[1] developed in the subject five-year reviews, the United States International Trade Commission (“Commission”) determines, pursuant to the Tariff Act of 1930 (“the Act”), that revocation of the countervailing and antidumping duty orders on citric acid and certain citrate salts from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.

Background

The Commission instituted these reviews on December 1, 2025 (90 FR 55172) and determined on March 6, 2026, that it would conduct expedited reviews (91 FR 14712, March 26, 2026).

The Commission made these determinations pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)). It completed and filed its determinations in these reviews on May 21, 2026. The ( printed page 30727) views of the Commission are contained in USITC Publication 5740 (May 2026), entitled Citric Acid and Certain Citrate Salts from China: Investigation Nos. 701-TA-456 and 731-TA-1152 (Third Review).